The down-regulation of preprotein convertase Bacillus subtilis protease/kexin type 9 (PCSK9) augments tumor infiltration by cytotoxic T-cells, improves the effectiveness of anti-PD-1 therapies, and is pivotal in the anti-tumor immune response (130). The gene discussed is PDCD1; the disease is neoplasm.